drugset / Trial / NCT04597359
To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring
Phase 2
Active not recruiting
360 enrolled
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI) · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
This phase II trial studies how well green tea catechins work in preventing progression of prostate cancer from a low risk stage to higher risk stages in men who are on active surveillance. Green tea catechins may stabilize prostate cancer and lower the chance of prostate growing.
Timeline
- Start
- 2021-10-05
- Primary completion
- 2032-12-31
- Completion
- 2032-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sinecatechins | Unknown | — | Oral |